Search

Health related quality of life measures as outcome parameters in middle ear diseases

Surely the only outcome needed for post-surgical ears is a better PTA? Marcus Neudert argues there should be more to it than that. To draw a comprehensive picture of the disease-associated restrictions in patients with chronic otitis media, audiometric outcome...

Physiological mechanisms of hyperacusis: an update

Hyperacusis is a heterogeneous and complex clinical entity, and proposals about physiological mechanisms should reflect these issues. Ben Auerbach helps us navigate through present knowledge in this area, and proposes future directions for research. Hyperacusis is a debilitating hearing disorder...

Why hearing above 8 kHz matters more than you think

This review explores the significance of extended high-frequency hearing loss (above 8 kHz) and why it may be worth doing clinically more frequently. There are many conditions that may hide underneath a normal audiogram, and one of the easiest to...

The future of treatments for hearing and balance: a 15 and 50-year perspective

Jameel Muzaffar and Manohar Bance paint a picture of what otology will look like 15 and 50 years’ time. Will we still need doctors? Will there still be an ENT news journal? The last 50 years have seen advances including...

The history of person-centred hearing care

In the World Report on Hearing, launched by the World Health Organization (WHO) on 3 March 2021, the use of person-centred care is highly recommended. In this article, we learn about the history of person-centred healthcare and hearing care. But...

The missing link: how migraine neurophysiology amplifies tinnitus

This article discusses an emerging hypothesis linking bothersome tinnitus with migraine-related sensory processing dysfunction. When evaluating patients with tinnitus, a range of contrasting experiences are noted, from mild, non-bothersome symptoms to those associated with significant distress – broadly corresponding to...

Innovative approaches to treating deafness

Shahar Taiber and Karen Avraham give us a summary of gene therapies for hearing loss, with an overview of limitations and what the future holds. Hearing loss is the most common sensory disorder. The last two decades have seen a...

The future of inner ear drug delivery

The techniques for delivering drugs to the inner ear system are evolving. Jeffrey Harris considers the myths, the facts and the potential for drug delivery innovations and how they can improve tomorrow’s hearing outcomes. The inner ear’s delicate membranous structure,...

Assessing extended high-frequency hearing

The frequency range of human hearing spans 20 Hz to 20 kHz. In the UK, standard audiometry usually assesses 0.25–8 kHz; the extended high frequencies (EHFs) are those above 8 kHz. The importance of assessing EHF hearing has been increasingly...

In conversation with Jeff Small and Navid Shahnaz

The impact of COVID-19 has been felt on all levels of society and deeply affected our lives. It has challenged us to find new ways of carrying on with our activities at home, work, and school. Jeff Small, Director and...

Developing medical devices for children: opportunities and challenges

The development of medical devices for infants and children lags significantly behind the development of devices for adults. While in the United States the Food and Drug Administration (FDA) has set up incentives for developing child age-specific pharmaceuticals, there is...